Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
ABC-AF Bleeding ScoreABC-AF Stroke ScoreABCD2 ScoreADD-RSAortic Valve Calcium ScoreAPPLE ScoreASCVD (Pooled Cohort)AVA (Continuity Equation)BAG-AHF ScoreBiplane Simpson EFBlood Pressure PercentilesBrugada Criteria (VT vs SVT)Cardiac Output IndexCHA2DS2-VAScCHADS2Cornell Voltage CriteriaCRUSADE Bleeding ScoreDAPT ScoreDASIDuke Treadmill ScoreE/A RatioEDACS ScoreEHMRGEHRA ScoreEmbolic Risk ScoreEROA (PISA Method)FFR (Fractional Flow Reserve)Fick Cardiac OutputFramingham 10-Year RiskFriedewald LDL EquationGorlin EquationGRACE ScoreGupta MICA (NSQIP)GWTG-HF ScoreH2FPEF ScoreHakki FormulaHAS-BLEDHEART PathwayHEART ScoreHEMORR2HAGEShs-Troponin 0h/1h ESC AlgorithmiFRINTERCHEST ScoreKillip ClassificationLee's RCRILV Mass IndexLV Stroke Work IndexMAGGIC Risk ScoreMAP CalculatorMartin/Hopkins LDLModified Duke CriteriaModified Sgarbossa CriteriaMVA (Pressure Half-Time)Non-HDL CholesterolNT-proBNP Age-Adjusted ThresholdsORBIT ScoreOttawa Heart Failure RiskPREVENT EquationsPulse PressurePVR CalculatorPVR IndexQRISK3QTc (Bazett)QTc (Fridericia)REVEAL 2.0 ScoreREVEAL Lite 2Reynolds Risk ScoreROSIRVSP CalculatorSchwartz Score (LQTS)SCORE2Seattle Heart Failure Model (SHFM)Sgarbossa CriteriaShock IndexSokolow-Lyon VoltageStroke Volume IndexSVR CalculatorSYNTAX ScoreSYNTAX Score IITAPSETeichholz FormulaTIMI (STEMI)TIMI (UA/NSTEMI)Troponin Delta CalculatorValvular GradientsVancouver Chest Pain RuleVereckei AlgorithmWATCHDM ScoreWilkins ScoreWood Units Calculator
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Stroke Volume Index

NEDA 2023 UpdateRisk-Adjusted SVI Stratification

Hemodynamic Inputs

mL

Calculated via LVOT diameter & VTI

m²

Body Surface Area

%

Ejection Fraction

Risk Profile

Requires Stroke Volume, BSA, and LVEF to determine adjusted prognostic risk based on latest NEDA findings.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

What is Stroke Volume Index (SVI)?

Stroke Volume Index (SVI) is the volume of blood ejected from the left ventricle per heartbeat, divided by the patient's body surface area (BSA). It normalizes cardiac output for patient size, allowing comparison across individuals. SVI is a key hemodynamic parameter that reflects left ventricular forward flow and helps distinguish between "true-severe" and "pseudo-severe" aortic stenosis (AS) in patients with low-gradient AS (mean gradient <40 mmHg, peak velocity <4 m/s). Unlike ejection fraction (EF), which measures the percentage of blood ejected, SVI measures the absolute volume normalized to BSA, making it sensitive to both systolic dysfunction and restrictive physiology (small LV cavity, concentric remodeling).

Primary Clinical Indications

Low-gradient severe aortic stenosis (AS): Differentiates "low-flow" from "normal-flow" states in patients with AVA ≤1.0 cm² but mean gradient <40 mmHg. SVI ≤35 mL/m² defines low-flow (classical or paradoxical).
Prognostic stratification in AS: SVI <30 mL/m² (preserved EF) or <35 mL/m² (reduced EF) identifies patients with significantly worse 1- and 3-year mortality, independent of AVA, symptoms, and cardiac damage stage.
Guiding aortic valve replacement (AVR) timing: Low SVI with dobutamine stress echo helps identify true-severe AS (SVI increases with dobutamine) vs pseudo-severe AS (SVI unchanged or decreases).
Heart failure with preserved ejection fraction (HFpEF): SVI <35 mL/m² is common in HFpEF (40-50% of patients) and predicts worse outcomes independent of LVEF.
Cardiac resynchronization therapy (CRT) response: Low SVI (<35 mL/m²) predicts worse CRT response and higher mortality.
Monitoring after AVR or TAVI: Improvement in SVI post-intervention (increase ≥5-10 mL/m²) correlates with symptom improvement and better long-term survival.

SVI vs Other Hemodynamic Parameters

ParameterDefinitionNormal RangeKey LimitationClinical Utility
Stroke Volume Index (SVI)SV / BSA (mL/m²)LV: 30-66 (men), 30-59 (women); RV: 28-75 (men), 29-66 (women)BSA-dependent (obesity underestimates, small body habitus overestimates)Low-flow AS, HFpEF, CRT response, prognosis
Stroke Volume (SV)EDV – ESV (mL)LV: 55-127 (men), 47-99 (women)Not indexed to body size (tall/muscular patients have higher SV)Cardiac output calculation, preload assessment
Ejection Fraction (EF)SV / EDV × 100%LV: 50-70% (men/women)Normal in HFpEF, concentric remodeling, and paradoxical low-flow ASSystolic function, heart failure classification
Cardiac Index (CI)CO / BSA (L/min/m²)2.5-4.0 L/min/m²Rate-dependent (heart rate), requires heart rate measurementShock classification, low-output states
Transvalvular Mean Gradient4V² (simplified Bernoulli)<40 mmHg: low-gradientFlow-dependent (underestimates in low-flow states)AS severity classification

Related Scores in Practice

In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the Aortic Valve Area, Lv Ejection Fraction, Cardiac Output Calculator or the Bsa Calculator to formulate a comprehensive care plan.

Last Comprehensive Review: 2026

Related Cardiovascular Tools

WATCHDM Score
EHMRG
ABC-AF Bleeding Score
ASCVD
QTc
SYNTAX Score
Hakki Formula
Sokolow-Lyon Voltage
PVR Calculator
REVEAL 2.0 Score
Cardiovascular CalculatorsCritical Care CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.

Recent Journal Updates

CancerJun 8, 2026
Clinicopathologic characteristics of early‐onset breast cancer among unselected young Black women

Clinical Context

We think this might be relevant to the clinical guidance for Stroke Volume Index (SVI).

Clinical Pharmacology TherapeuticsJun 6, 2026
Correction to “A Phase 1 Study Evaluating the Pharmacokinetics and Safety of Avacopan in Participants With End‐Stage Kidney Disease on Hemodialysis”

Clinical Context

We think this might be relevant to the clinical guidance for Stroke Volume Index (SVI).

CancerJun 5, 2026
Site‐ and age‐dependent associations between Fusobacterium nucleatum and colorectal cancer mortality

Clinical Context

We think this might be relevant to the clinical guidance for Stroke Volume Index (SVI).